Q BioMed Inc. Contracts & Agreements
61 Contracts & Agreements
- Business Finance (44 contracts)
- Business Operations (5)
- Human Resources (2)
- Intellectual Property (3)
- Uncategorized (7)
- Amendment To Patent and Technology License and Purchase Option Agreement, dated March 26, 2019, among the Company and Mannin Research Inc (Filed With SEC on February 28, 2022)
- Conversion Agreement, dated January 21, 2022 (Filed With SEC on January 25, 2022)
- Securities Purchase Agreement, dated September 29, 2021 (Filed With SEC on October 7, 2021)
- The Convertible Debenture (Filed With SEC on October 7, 2021)
- Securities Purchase Agreement, Dated July 26, 2021 (Filed With SEC on July 30, 2021)
- Form of Convertible Promissory Note (Filed With SEC on July 30, 2021)
- Form of Warrant (Filed With SEC on July 30, 2021)
- Amendment Agreement, Date July 22, 2021 (Filed With SEC on July 30, 2021)
- Securities Purchase Agreement, dated February 12, 2021 (Filed With SEC on February 16, 2021)
- Form of Debenture (Filed With SEC on February 16, 2021)
- Securities Purchase Agreement, dated December 23, 2020 (Filed With SEC on December 29, 2020)
- Form of Debenture (Filed With SEC on December 29, 2020)
- Amendment Agreement, dated December 23, 2020 (Filed With SEC on December 29, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on December 29, 2020)
- Form of Warrant (Filed With SEC on December 29, 2020)
- Securities Purchase Agreement, dated April 6, 2020 (Filed With SEC on April 7, 2020)
- Registration Rights Agreement, dated April 6, 2020 (Filed With SEC on April 7, 2020)
- Description of Securities (Filed With SEC on February 28, 2020)
- Securities Purchase Agreement, dated December 5, 2019 (Filed With SEC on December 12, 2019)
- Form of Debenture (Filed With SEC on December 12, 2019)
- Securities Purchase Agreement, dated October 11, 2019 (Filed With SEC on October 15, 2019)
- Form of Debenture (Filed With SEC on October 15, 2019)
- Securities Purchase Agreement, dated August 28, 2019 (Filed With SEC on September 6, 2019)
- The Convertible Debenture (Filed With SEC on September 6, 2019)
- Asset Purchase Agreement, dated November 23, 2018 (Filed With SEC on November 28, 2018)
- Securities Purchase Agreement, dated September 21, 2018 (Filed With SEC on September 24, 2018)
- Registration Rights Agreement, dated September 21, 2018 (Filed With SEC on September 24, 2018)
- Form of Debenture (Filed With SEC on September 24, 2018)
- Non-qualified Stock Option Agreement (Filed With SEC on February 20, 2018)
- Form of Q BIOMED INC. [*] Share of Common Stock and One Warrant to Purchase [*] Share of Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on January 12, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 12, 2018)
- COMMON STOCK PURCHASE WARRANT Q BIOMED INC. (Filed With SEC on January 10, 2018)
- Form of Q BIOMED INC. [*] Share of Common Stock and One Warrant to Purchase [*] Share of Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on January 10, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 10, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 2, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 2, 2017)
- Void after 5:00 p.m. (New York time) on [-----]. (Filed With SEC on August 2, 2017)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on August 2, 2017)
- TECHNOLOGY LICENSE AGREEMENT BETWEEN OMRF, RGCB AND QBIOMED (Filed With SEC on July 25, 2017)
- TECHNOLOGY LICENSE AGREEMENT BETWEEN OMRF, RGCB AND QBIOMED (Filed With SEC on June 15, 2017)
- Form of Incentive Stock Option Agreement (Filed With SEC on June 9, 2017)
- Form of Warrant (Filed With SEC on June 9, 2017)
- Executive Services Agreement, dated June 5, 2017, between Denis Corin and Q BioMed Cayman SEZC (Filed With SEC on June 9, 2017)
- License Agreement on Patent & Know-How/Technology (Filed With SEC on April 25, 2017)
- SUPPLEMENT AND AMENDMENT AGREEMENT (Filed With SEC on March 10, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 30, 2016)
- SECURITY AGREEMENT (in favor of YA II CD, Ltd.) (Filed With SEC on November 30, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 30, 2016)
- Q BIOMED INC. Secured Convertible Debenture (Filed With SEC on November 30, 2016)
- PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENT (Filed With SEC on October 17, 2016)
- FIRST AMENDMENT TO PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENT (Filed With SEC on October 17, 2016)
- PATENT AND TECHNOLOGY LICENSE AND PURCHASE OPTION AGREEMENT (Filed With SEC on March 11, 2016)
- ADVISORY AGREEMENT (Filed With SEC on January 13, 2016)
- Q BIOMED, INC. CONVERTIBLE NOTE (Filed With SEC on January 13, 2016)
- CONSULTING AGREEMENT (Filed With SEC on January 13, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 13, 2016)
- Exhibit 10.8, 1 (Filed With SEC on January 13, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 13, 2016)
- Q BIOMED, INC. CONVERTIBLE NOTE (Filed With SEC on January 13, 2016)
- ADVISORY AGREEMENT (Filed With SEC on June 16, 2015)
- ADVISORY AGREEMENT (Filed With SEC on April 30, 2015)
